Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria.
BACKGROUND: Treatments for uncomplicated falciparum malaria should have high cure rates. The World Health Organization has recently set a target cure rate of 95% assessed at 28 days. The use of more effective drugs, with longer periods of patient follow-up, and parasite genotyping to distinguish re...
Hlavní autoři: | Stepniewska, K, White, N |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
BioMed Central
2006
|
Podobné jednotky
-
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
Autor: Stepniewska Kasia, a další
Vydáno: (2006-12-01) -
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
Autor: Borrmann, S, a další
Vydáno: (2008) -
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria
Autor: Borrmann, S, a další
Vydáno: (2008) -
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
Autor: Steffen Borrmann, a další
Vydáno: (2008-11-01) -
Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria.
Autor: Pukrittayakamee, S, a další
Vydáno: (2003)